SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: February 2015

    What They Really Mean . . .

    Posted on February 15, 2015 by droberts
  • February 15, 2015

    What They Really Mean . . .

    Sometimes, it’s wise to read news items in reverse. by Dan Roberts The latest magnifying technology, a switchable telescopic contact lens, has been receiving wide media attention this past week. If you read the news from the top down, and you anxiously call your eye care specialist before reading all the way to the bottom, […]

      Also posted in
    • Latest News
  • Notal Vision Device Shows 94% Success at Early Detection of Age-Related Macular Degeneration

    Posted on February 10, 2015January 12, 2019 by droberts
  • February 10, 2015

    Notal Vision Device Shows 94% Success at Early Detection of Age-Related Macular Degeneration

    A National Eye Institute study has reported an impressive success rate at early detection of wet (neovascular) age-related macular degeneration (AMD). The study compared two groups of dry AMD patients and compared the proportion within each group for patients presenting with 20/40 acuity or better when their wet AMD was detected. An experimental group used […]

      Also posted in
    • Latest News
    • Research and Developments
  • FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema

    Posted on February 7, 2015 by droberts
  • February 7, 2015

    FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema

    The U.S. Food and Drug Administration announced today that they have expanded the approved use for Lucentis 0.3 mg (Genentech) to treat diabetic retinopathy in patients with diabetic macular edema. The FDA previously had approved Lucentis to treat DME and macular edema secondary to retinal vein occlusions, both of which cause fluid to leak into […]

      Also posted in
    • Latest News
    • Therapies, Treatments, and Procedures
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.